We are live on ! Find out more
TCRR

TCR2 Therapeutics Inc. Common Stock
TCRR

Delisted

TCRR was delisted on the 31st of May, 2023.

Back to rankings

64 hedge funds and large institutions have $234M invested in TCR2 Therapeutics Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

111% more capital invested

Capital invested by funds: $111M → $234M (+$123M)

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

28% more funds holding

Funds holding: 50 → 64 (+14)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
64
Holders Change
+14
Holders Change %
+28%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
26
Reduced
13
Closed
4
Calls
$633K
Puts
–
Net Calls
+$633K
Net Calls Change
+$742K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.31M
2
Morgan Stanley
Morgan Stanley
New York
+$1.54M
3
Northern Trust
Northern Trust
Illinois
+$1.17M
4
GPCM
Granite Point Capital Management
Massachusetts
+$1.15M
5
State Street
State Street
Massachusetts
+$640K

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$980K
2
AG
Artal Group
Luxembourg
-$577K
3
DCM
DAFNA Capital Management
California
-$376K
4
Millennium Management
Millennium Management
New York
-$360K
5
Ameriprise
Ameriprise
Minnesota
-$295K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$613K -$360K -31,168 -44%
ECM
27
Endurant Capital Management
California
$591K +$444K +38,494 New
WOSD
28
WFA of San Diego
California
$540K +$54.6K +4,733 New
Renaissance Technologies
29
Renaissance Technologies
New York
$524K -$198K -17,200 -34%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$507K +$381K +33,000 New
SFM
31
Sphera Funds Management
Israel
$461K +$346K +30,000 New
First Trust Advisors
32
First Trust Advisors
Illinois
$430K +$23.3K +2,022 +8%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$377K +$70.3K +6,098 +33%
IA
34
IndexIQ Advisors
New York
$353K -$63.2K -5,481 -19%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$342K +$114K +9,922 +80%
GH
36
GAM Holding
Switzerland
$338K +$254K +22,000 New
Goldman Sachs
37
Goldman Sachs
New York
$256K +$192K +16,668 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$247K +$186K +16,100 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$230K +$25.3K +2,193 +17%
M&T Bank
40
M&T Bank
New York
$212K +$10.8K +934 +7%
Ameriprise
41
Ameriprise
Minnesota
$193K -$295K -25,560 -67%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$166K +$123K +10,644 New
AIG
43
American International Group
New York
$153K +$34.9K +3,028 +44%
Barclays
44
Barclays
United Kingdom
$138K +$58.5K +5,076 +130%
SG Americas Securities
45
SG Americas Securities
New York
$137K +$103K +8,910 New
MIM
46
MetLife Investment Management
New Jersey
$126K +$94.7K +8,211 New
Deutsche Bank
47
Deutsche Bank
Germany
$121K +$48.8K +4,230 +115%
Bank of America
48
Bank of America
North Carolina
$111K +$43.5K +3,773 +108%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$87.1K +$65.4K +5,670 New
UBS Group
50
UBS Group
Switzerland
$79K -$19.2K -1,666 -24%
1
2
3

TCRR Hedge Fund Activity: Q2 2020 in Review

64 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in TCR2 Therapeutics Inc. Common Stock (TCRR) for Q2 2020, worth a combined $234M — up 111% from $111M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TCRR positions and 4 closed out — a net gain of 14 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $2.31M. The largest seller was Victory Capital Management, cutting an estimated $980K.

  • 64 institutional investors held TCR2 Therapeutics Inc. Common Stock (TCRR) as of Q2 2020, up from 50 in Q1 2020.
  • Funds reported $234M of TCR2 Therapeutics Inc. Common Stock stock for Q2 2020, up 111% quarter-over-quarter.
  • 18 funds opened new TCR2 Therapeutics Inc. Common Stock positions in Q2 2020 and 4 closed out, a net change of +14 holders.
  • The largest TCR2 Therapeutics Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $2.31M added.
  • The largest TCR2 Therapeutics Inc. Common Stock seller in Q2 2020 was Victory Capital Management, an estimated $980K sold.

Based on aggregated 13F filings for Q2 2020.